Literature DB >> 24385237

Immune stimulation by exogenous melatonin during experimental endotoxemia.

Katharina Effenberger-Neidnicht1, Lisa Brencher, Martina Broecker-Preuss, Tim Hamburger, Frank Petrat, Herbert de Groot.   

Abstract

Melatonin has been shown to enhance the immune response under immune-compromised conditions. However, its immune-modulatory effects under inflammatory conditions are unclear at present. Both pro- and anti-inflammation has been reported. To study time-dependent effects of melatonin on the general immune response during endotoxemia in more detail, we used two models in male rats: per-acute endotoxemia was induced by lipopolysaccharide (LPS) bolus injection (2.5 mg/kg), sub-acute endotoxemia by LPS infusion (2.5 mg/kg × h). Melatonin was applied directly before and 2 h after LPS administration (3 mg/kg, each). The LPS-induced formation of the pro-inflammatory cytokines tumor necrosis factor alpha, interferon-gamma, interleukin (IL)-1α/β, IL-5, and IL-6 and of the anti-inflammatory cytokine IL-10 was further amplified by melatonin, although it was only significant during per-acute endotoxemia. In both models, melatonin had no effect on the LPS-induced nitric oxide release. These findings show that exogenous melatonin is capable of enhancing the general immune response under inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24385237     DOI: 10.1007/s10753-013-9792-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  63 in total

1.  Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain.

Authors:  Ethika Tyagi; Rahul Agrawal; Chandishwar Nath; Rakesh Shukla
Journal:  Eur J Pharmacol       Date:  2010-05-05       Impact factor: 4.432

2.  Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Latifa Naji; José M Fernández-Santos; Inés Martín-Lacave; Juan M Guerrero; Juan R Calvo
Journal:  J Pineal Res       Date:  2005-11       Impact factor: 13.007

Review 3.  Toxicology of melatonin.

Authors:  B Guardiola-Lemaître
Journal:  J Biol Rhythms       Date:  1997-12       Impact factor: 3.182

4.  Protective effects of tryptophan on neuro-inflammation in rats after administering lipopolysaccharide.

Authors:  A R Del Angel-Meza; A J Dávalos-Marín; L L Ontiveros-Martinez; G G Ortiz; C Beas-Zarate; V Chaparro-Huerta; B M Torres-Mendoza; O K Bitzer-Quintero
Journal:  Biomed Pharmacother       Date:  2011-05-05       Impact factor: 6.529

5.  Circadian interleukin-6 secretion and quantity and depth of sleep.

Authors:  A N Vgontzas; D A Papanicolaou; E O Bixler; A Lotsikas; K Zachman; A Kales; P Prolo; M L Wong; J Licinio; P W Gold; R C Hermida; G Mastorakos; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

Review 6.  The immunotherapeutic potential of melatonin.

Authors:  G J Maestroni
Journal:  Expert Opin Investig Drugs       Date:  2001-03       Impact factor: 6.206

Review 7.  Minireview: Entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals.

Authors:  Etienne Challet
Journal:  Endocrinology       Date:  2007-09-27       Impact factor: 4.736

8.  Protective effect of melatonin against liver injury in mice induced by Bacillus Calmette-Guerin plus lipopolysaccharide.

Authors:  Hua Wang; Wei Wei; Yu-Xian Shen; Chen Dong; Ling-Ling Zhang; Ni-Ping Wang; Li Yue; Shu-Yun Xu
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

9.  Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system.

Authors:  A Carrillo-Vico; A García-Pergañeda; L Naji; J R Calvo; M P Romero; J M Guerrero
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

10.  Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis.

Authors:  D A Lowes; N R Webster; M P Murphy; H F Galley
Journal:  Br J Anaesth       Date:  2013-02-04       Impact factor: 9.166

View more
  7 in total

Review 1.  Mechanisms of Hemolysis During Sepsis.

Authors:  Katharina Effenberger-Neidnicht; Matthias Hartmann
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 2.  Utilizing melatonin to combat bacterial infections and septic injury.

Authors:  Wei Hu; Chao Deng; Zhiqiang Ma; Dongjin Wang; Chongxi Fan; Tian Li; Shouyin Di; Bing Gong; Russel J Reiter; Yang Yang
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

3.  Administration of Exogenous Melatonin After the Onset of Systemic Inflammation Is Hardly Beneficial.

Authors:  Lisa Brencher; Maren Oude Lansink; Katharina Effenberger-Neidnicht
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

4.  Effects of AANAT overexpression on the inflammatory responses and autophagy activity in the cellular and transgenic animal levels.

Authors:  Jingli Tao; Minghui Yang; Hao Wu; Teng Ma; Changjiu He; Menglong Chai; Xiaosheng Zhang; Jinlong Zhang; Fangrong Ding; Sutian Wang; Shoulong Deng; Kuanfeng Zhu; Yukun Song; Pengyun Ji; Haijun Liu; Zhengxing Lian; Guoshi Liu
Journal:  Autophagy       Date:  2018-08-04       Impact factor: 16.016

5.  Therapeutic effects of physostigmine during systemic inflammation.

Authors:  Katharina Effenberger-Neidnicht; Johannes Jägers; Rabea Verhaegh; Michael Kirsch
Journal:  J Inflamm Res       Date:  2018-12-07

6.  Altered endotoxin responsiveness in healthy children with Down syndrome.

Authors:  Dean Huggard; Fiona McGrane; Niamh Lagan; Edna Roche; Joanne Balfe; Timothy Ronan Leahy; Orla Franklin; Ana Moreno; Ashanty M Melo; Derek G Doherty; Eleanor J Molloy
Journal:  BMC Immunol       Date:  2018-11-03       Impact factor: 3.615

7.  Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study.

Authors:  Henrik Galbo; Lisbeth Kall
Journal:  Arthritis Res Ther       Date:  2016-07-26       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.